Abstract
The maintenance of pancreatic β-cells normal functioning is crucial for insulin production and glucose homeostasis. Inadequate insulin secretion due to β-cell dysfunction can lead to different types of diabetes mellitus. Though it is widely recognized that both environmental and genetic factors play important roles, the exact molecular mechanism that leads to β -cell failure is still unclear. MicroRNAs (miRNAs) regulate numerous physiological and pathophysiological processes at the epigenetic level. miRNAs have been reported to participate in the process of pancreatic development and insulin biosynthesis. Some miRNAs may control insulin secretion and exocytosis through regulating ATP/ADP ratio. In this review, we will summarize the pathological roles of miRNAs in β-cell dysfunction and briefly discuss miRNAs as possible biomarkers and potential pharmaceutical target for diabetes mellitus.
Current Signal Transduction Therapy
Title:MicroRNAs in Diabetic β Cell Dysfunction and their Role as Biomarkers
Volume: 9 Issue: 2
Author(s): Yaxi Chen, Haoming Tian and Xijie Yu
Affiliation:
Keywords: Biomarker, β cells, diabetes, insulin, miRNAs.
Abstract: The maintenance of pancreatic β-cells normal functioning is crucial for insulin production and glucose homeostasis. Inadequate insulin secretion due to β-cell dysfunction can lead to different types of diabetes mellitus. Though it is widely recognized that both environmental and genetic factors play important roles, the exact molecular mechanism that leads to β -cell failure is still unclear. MicroRNAs (miRNAs) regulate numerous physiological and pathophysiological processes at the epigenetic level. miRNAs have been reported to participate in the process of pancreatic development and insulin biosynthesis. Some miRNAs may control insulin secretion and exocytosis through regulating ATP/ADP ratio. In this review, we will summarize the pathological roles of miRNAs in β-cell dysfunction and briefly discuss miRNAs as possible biomarkers and potential pharmaceutical target for diabetes mellitus.
Export Options
About this article
Cite this article as:
Chen Yaxi, Tian Haoming and Yu Xijie, MicroRNAs in Diabetic β Cell Dysfunction and their Role as Biomarkers, Current Signal Transduction Therapy 2014; 9 (2) . https://dx.doi.org/10.2174/1574362410666150114230309
DOI https://dx.doi.org/10.2174/1574362410666150114230309 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Indoor Dust Levels of Perfluoroalkyl Substances (PFASs) and the Role of Ingestion as an Exposure Pathway: A Review
Current Organic Chemistry Biomarkers Associated with Stroke Risk in Atrial Fibrillation
Current Medicinal Chemistry Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease
Current Vascular Pharmacology Structural and Functional Characterization of Pathogenic Non- Synonymous Genetic Mutations of Human Insulin-Degrading Enzyme by In Silico Methods
CNS & Neurological Disorders - Drug Targets Halving Your Cake and Eating it, Too: A Case-based Discussion and Review of Metabolic Rehabilitation for Obese Adults with Diabetes
Current Diabetes Reviews Ferritin and Percent Transferrin Saturation Levels Predict Type 2 Diabetes Risk and Cardiovascular Disease Outcomes
Current Diabetes Reviews Lipid Disorders in Diabetes Mellitus and Current Management
Current Pharmaceutical Analysis Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery
Current Medicinal Chemistry Study of Possible Relation between Fasting Plasma Glucagon, Gestational Diabetes and Development of Type 2 DM
Current Diabetes Reviews Diagnosis and Prognosis of Fetal Cardiomyopathies: A Review
Current Pharmaceutical Design Nutritional Metabolomics: Lessons from Companion Animals
Current Metabolomics Editorial: [Statins and Cardiovascular Events in Patients with End-Stage Renal Disease on Hemodialysis. The AURORA Results Suggest the Need for Earlier Intervention]
Current Vascular Pharmacology Ghrelin and Motilin in the Gastrointestinal System
Current Pharmaceutical Design Antifungal Agents in Hematopoietic Stem Cell Transplantation
Current Pharmaceutical Design Statins in the Treatment of Acute Ischemic Stroke
Current Pharmaceutical Biotechnology Development of a Fermentation Process for Utilization of Emblica Officinalis Gaertn (Amla) Candy Waste for Production of Natural Vinegar
Current Nutrition & Food Science Stem/Progenitor Cells and Biodegradable Scaffolds in the Treatment of Retinal Degenerative Diseases
Current Stem Cell Research & Therapy Role of the Sympathetic Nervous Activity in Hypertension-Update in 2013
Current Hypertension Reviews Beneficial Actions of Polyunsaturated Fatty Acids in Cardiovascular Diseases: But, How and Why?
Current Nutrition & Food Science Obesity and Metabolic Syndrome Affect the Cholinergic Transmission a nd Cognitive Functions
CNS & Neurological Disorders - Drug Targets